Share performance
Tools to track your share performance.
The home of dsm-firmenich’s share information
dsm-firmenich shares are held via Euroclear and SIX SIS. Investors can hold shares via either Euroclear Nederland or SIX SIS. However, in order to trade shares on Euronext Amsterdam, investors must settle via Euroclear Nederland. This means shares will need to be held via Euroclear Nederland.
DSM- Firmenich AG has established a new sponsored Level I program with Deutsche Bank, appointed as depositary bank on December 21, 2023 and began trading as DSFIY on OTC.
As of April 4, 2024, DSM Firmenich AG was upgraded to OTCQX® Best Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
About DSM Firmenich AG
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
On May 14, 2024, the Enterprise Chamber of the Court of Appeal in Amsterdam (the Enterprise Chamber), the Netherlands rendered its judgment in the statutory buy-out proceedings initiated by DSM-Firmenich AG (the Company) to acquire any shares of DSM B.V. (DSM) not already acquired by the Company in its previously completed voluntary cash tender offers for all outstanding DSM ordinary shares (the Shares).
The Enterprise Chamber ordered all remaining DSM shareholders to transfer the unencumbered right to their Shares to the Company. It determined that €116 is the fair price per Share, subject to an increase by statutory interest calculated from May 3, 2023 until the date of transfer or consignment of the Shares, and a decrease by any distributions that become payable on the Shares in the aforementioned period. The Company was ordered to pay this fair price plus statutory interest and minus distributions in exchange for the transfer of the unencumbered right to the Shares, which resulted in an amount of €100.38 per Share.
To execute this judgment, on July 5, 2024, the Company paid this amount of €100.38 per Share into consignment with the Dutch Consignment Office (a body of the Dutch Ministry of Finance) for all Shares not offered to the Company within the voluntary transfer period that ended on 2 July 2024. With this payment, the unencumbered title to such Shares have transferred to the Company by operation of law. The former holders of these DSM shares can claim the amount of 100.38 per Share from the Consignment Office.
Former shareholders can ask their brokers to arrange this payment through Euroclear Nederland, who typically will request payment from the Consignment Office on behalf of a former shareholder.
The consignment fund procedure of the Consignment Office can be found on: https://www.rijksoverheid.nl/onderwerpen/consignatiekas/claim-indienen
Contact address:
Ministerie van Financiën, Consignatiekas, Postbus 20201, 2500 EE Den Haag. Phone: +31 (0)88 442 8000.
Tools to track your share performance.
dsm-firmenich bonds, other debt, credit facilities and credit ratings.
All the key details about dsm-firmenich’s dividend policy.